![David Hoey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hoey
Directeur/Membre du Conseil chez
UNIVERSAL BIOSENSORS, INC.
Profil
David L.
Hoey is currently Independent Non-Executive Director at Universal Biosensors, Inc. since 2016, Non-Executive Director at Universal Biosensors Pty Ltd. since 2016, Director at Universal Biosensors BV since 2021, and Director at Universal Biosensors LLC since 2021.
Former roles include President, Chief Executive Officer & Director at Vaxxas Pty Ltd. from 2012 to 2025, Chief Executive Officer & Director at Vaxxas, Inc., Director at Bligh Ventures Ltd., Director & Vice President-Business Development at PathoGenetix, Inc. from 2010 to 2012, Vice President-Business Development at Molten Metal Technology, Inc., and Vice President-Marketing & Business Development at InfoLibria, Inc.
Postes actifs de David Hoey
| Sociétés | Poste | Début |
|---|---|---|
| UNIVERSAL BIOSENSORS, INC. | Directeur/Membre du Conseil | 02/03/2016 |
Universal Biosensors Pty Ltd.
 Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic test systems | Directeur/Membre du Conseil | 01/03/2016 |
Universal Biosensors LLC | Directeur/Membre du Conseil | 31/08/2021 |
Universal Biosensors BV | Directeur/Membre du Conseil | 15/09/2021 |
Anciens postes connus de David Hoey
| Sociétés | Poste | Fin |
|---|---|---|
Vaxxas, Inc.
 Vaxxas, Inc. Aerospace & DefenseElectronic Technology Part of Vaxxas Pty Ltd., Vaxxas, Inc. is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density microarray patch (HD-MAP). The company is based in Cambridge, MA. Vaxxas is targeting initial applications in infectious disease and oncology. The CEO of the company is David L. Hoey. | Directeur Général | 07/01/2026 |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Directeur Général | 25/08/2025 |
PathoGenetix, Inc.
 PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Directeur/Membre du Conseil | 01/10/2012 |
Bligh Ventures Ltd.
 Bligh Ventures Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides management services and capital to enterprises | Directeur/Membre du Conseil | - |
Molten Metal Technology, Inc.
 Molten Metal Technology, Inc. Environmental ServicesIndustrial Services Engages in innovative and proprietary | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Molten Metal Technology, Inc.
Molten Metal Technology, Inc. Environmental ServicesIndustrial Services Engages in innovative and proprietary | Industrial Services |
Universal Biosensors, Inc.
 Universal Biosensors, Inc. Medical SpecialtiesHealth Technology Manufactures vitro diagnostic test devices | Health Technology |
InfoLibria, Inc.
 InfoLibria, Inc. Computer Processing HardwareElectronic Technology Develops and provides content distribution & communications hardware and software solutions | Electronic Technology |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology Provides biological technological products and services | Health Technology |
Bligh Ventures Ltd.
Bligh Ventures Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides management services and capital to enterprises | Miscellaneous |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic test systems | Health Technology |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Develops and commercializes needle-free vaccine delivery solutions | Health Technology |
Vaxxas, Inc.
Vaxxas, Inc. Aerospace & DefenseElectronic Technology Part of Vaxxas Pty Ltd., Vaxxas, Inc. is a privately held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its proprietary high-density microarray patch (HD-MAP). The company is based in Cambridge, MA. Vaxxas is targeting initial applications in infectious disease and oncology. The CEO of the company is David L. Hoey. | Electronic Technology |
Universal Biosensors BV | |
Universal Biosensors LLC |
